Zepbound, a drug with the main active ingredient tirzepatide, was found to be more helpful in helping people lose weight than ...

A new weight-loss jab will be rolled out on the NHS in England - but it could take 12 years for everyone to receive it, the ...

A new study is shedding light on which of two drugs currently approved by the U.S. Food and Drug Administration for weight ...

People who took Zepbound, Eli Lilly’s weight loss drug, shed more pounds than those on Novo Nordisk’s Wegovy in a clinical ...

Analysts see the market for GLP-1 weight loss treatments rising to around $70 billion over the next five years.

Mounjaro will be made available on the NHS but the rollout will be phased, with only those with the highest need getting the ...

Mounjaro will be rolled out gradually as officials said a "difficult decision" had to be made in order to "protect other ...

The NHS spending watchdog has recommended Mounjaro – also known as tirzepatide and made by Eli Lilly – for those with a body ...

The NHS will deny 90 per cent of eligible obese patients the “King Kong” of weight loss jabs, citing budget pressures. The ...

Final draft guidance published by Nice shows NHS England requested that Mounjaro is rolled out over a period of 12 years. The ...

Eli Lilly's weight-loss drug Zepbound outperformed Novo Nordisk's Wegovy in a head-to-head trial, leading to a rise ...

The rise of weight loss drugs is not only changing individual lives, but also reshaping large sections of the economy.